Figure 3.
Efficiency frontier for secondary analysis with HRQoL adjustment for PA patients treated with mineralocorticoid-receptor antagonist alone. Only non-dominated strategies shown.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.